Chinook Therapeutics, Inc. - stock earnings
Stock symbol KDNY is outdated, potentially delisted? Maybe it is available on other exchange?
KDNY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -66.9 million USD | 1.0 million USD |
| 2022Q4 | -62.6 million USD | 512000 USD |
| 2022Q3 | -56.0 million USD | 2.5 million USD |
| 2022Q2 | -37.6 million USD | 418000 USD |
| 2022Q1 | -31.7 million USD | 2.7 million USD |
| 2021Q4 | 7.5 million USD | 51.2 million USD |
| 2021Q3 | -30.7 million USD | 4000 USD |
| 2021Q2 | -42.6 million USD | 34000 USD |
| 2021Q1 | -37.2 million USD | 351000 USD |
| 2020Q4 | -34.4 million USD | 413500 USD |
| 2020Q3 | -34.4 million USD | 413500 USD |
KDNY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -187.9 million USD | 6.1 million USD |
| 2021 | -102.9 million USD | 51.6 million USD |
| 2020 | -81.6 million USD | 827000 USD |
| 2019 | -46.5 million USD | ? USD |
| 2018 | -4.1 million USD | ? USD |
KDNY
Price: $40.39
52 week price:
Earnings Per Share: -3.45 USD
P/E Ratio: -2.01
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 406500
Market Capitalization: 1.5 billion